Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Shanghai MicroPort Endovascular MedTech Group Co Ltd

688016.SS ✓ COMPLIANTFree checks used up today ☆ Track — members

Shanghai Stock Exchange · Healthcare · Medical Equipment, Supplies & Distribution ·

China Small Cap Analyst: BUY

Last Close

$12.89

▲ +4.21%

Market Cap $1.59B · Vol 2.53M

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

17.81

FWD: 14.96

Market Cap

$1.59B

Small Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

+12.60%

YoY

RSI (14)

54.41

Momentum

Beta

1.06

vs Market

52W High

$17.41

23.32% below

52W Low

$12.31

5.10% above

Volume

2.53M

Avg 1.08M

P/B

2.67

Price-to-book

ROE

14.21%

Return on equity

Free Float

59.12%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Shanghai MicroPort Endovascular MedTech Group Co Ltd (688016.SS) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 688016.SS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.23%

+0.46%

-7.56%

-16.08%

YTD

-6.32%

-14.13%

-27.75%

-44.86%

Financials & Valuation

TTM · Annual

Total Revenue	$193.14M
Net Income	$79.32M
Revenue Growth (YoY)	+11.13%
Gross Margin	70.40%
Operating Margin	46.91%
Net Profit Margin	41.07%
ROE	14.21%
ROA · ROIC	14.63% · 13.92%

P/E Ratio	17.81
Forward P/E (FY1)	14.96
PEG Ratio	1.38
P/S	8.22
P/B	2.67
P/FCF	41.12
EPS Growth	+12.60%
Outstanding Shares	123.26M

Technical Indicators

50-Day SMA	$12.98
200-Day SMA	$14.28
RSI (14)	54.41
Beta	1.06
52-Week High	$17.41
52-Week Low	$12.31

Volume Today	2.53M
Avg Daily Volume (30D)	1.08M
Relative Volume	2.33x
Volatility (10D)	34.49
Volatility (30D)	24.99
Free Float	59.12%

Analyst Consensus

BUY

Current Price $12.89

Mean Target $20.39

52W Low$12.31 52W High$17.41

Current

Target

$12.31 $17.41

Current Analyst target

+58.20% upside potential · 4 analysts

Identifiers

ExchangeShanghai Stock Exchange

FIGIBBG00G6LFKZ2

ISINCNE100003MJ5

CountryChina

Sub-IndustryMedical Devices & Implants

Earnings DateOct 29, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SYK Stryker Corporation -6.38% GKOS Glaukos Corporation -2.01% SN..L Smith & Nephew PLC -1.20% SNN Smith & Nephew PLC -2.33% 300896.SZ Imeik Technology Development Co Ltd +1.34%

Company Profile

Shanghai MicroPort Endovascular MedTech Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of interventional medical devices for the aorta and peripheral blood vessels. The Company's products are mainly categorized into aortic stents, peripheral vascular devices and others. The aortic stent products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, and other surgical accessories. The peripheral vascular and other products mainly include intraoperative stent systems, peripheral arteries, peripheral veins, interventional oncology devices, and peripheral vascular surgical accessories. The Company conducts its businesses in domestic and overseas markets.